New Hampshire's bioscience industry has experienced significant growth, employing 9,330 individuals in 2023, marking a 27.9% increase since 2019. This growth surpasses the national job growth rate in the bioscience sector, highlighting the state's emerging prominence in this field [c3f95927].
The average wage for bioscience workers in New Hampshire is $136,164, which is 79% higher than the state's average wage. This wage increase reflects the high demand for skilled professionals within the industry [c3f95927].
In 2022, bioscience companies in New Hampshire reported research and development expenditures totaling $238.8 million. This investment underscores the commitment to innovation and advancement in the sector [c3f95927].
A notable development in December 2024 was the awarding of a $44 million grant to the Nashua ReGen Valley TechHub, aimed at further enhancing the state's bioscience capabilities and fostering job growth [c3f95927].
New Hampshire also secured 399 bioscience patents in 2023, ranking sixth nationally, which illustrates the state's strong innovation landscape. Over the past five years, the industry attracted $388 million in venture capital investments, indicating robust investor confidence in its potential [c3f95927].
The total economic impact of the bioscience industry in the United States reached $3.2 trillion in 2023, emphasizing the sector's significance not only in New Hampshire but across the nation [c3f95927].
These findings were detailed in a report released by BIO and the Council of State Bioscience Associations, with Andrea Hechavarria serving as the president and CEO of NH Life Sciences. This report highlights the substantial contributions of the bioscience industry to New Hampshire's economy and its role in driving innovation and job creation [c3f95927].